Takeda Pharmaceutical Company Limited
DE ˙ DB ˙ JP3463000004
28,33 € ↑0,12 (0,43%)
2026-04-24
DEL PRIS
SecurityDE:TKD / Takeda Pharmaceutical Company Limited
InstitutionBlackRock Variable Series Funds, Inc. - BlackRock Managed Volatility V.I. Fund Class I
Latest Disclosed Ownership9,200 shares
Latest Disclosed Value $ 284,031
BlackRock Variable Series Funds, Inc. - BlackRock Managed Volatility V.I. Fund Class I reports 12.20% increase in ownership of TKD / Takeda Pharmaceutical Company Limited

On August 28, 2025 - BlackRock Variable Series Funds, Inc. - BlackRock Managed Volatility V.I. Fund Class I filed a NPORT-P form disclosing ownership of 9,200 shares of Takeda Pharmaceutical Company Limited (DE:TKD) valued at $239,384 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 27, 2025 disclosing 8,200 shares of Takeda Pharmaceutical Company Limited. This represents a change in shares of 12.20% during the quarter. The current value of the position is $260,636 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-08-28 2025-06-30 NP Takeda Pharmaceutical Co. EC JP3463000004 9,200 1,000 12.20 284 16.87 0.1870
2025-05-27 2025-03-31 NP Takeda Pharmaceutical Co. EC JP3463000004 8,200 1,000 13.89 243 27.89 0.1622
2025-02-27 2024-12-31 NP Takeda Pharmaceutical Co. EC JP3463000004 7,200 0 0.00 191 -8.21 0.1178
2024-11-26 2024-09-30 NP Takeda Pharmaceutical Co. EC JP3463000004 7,200 2,900 67.44 207 86.49 0.1275
2024-08-27 2024-06-30 NP Takeda Pharmaceutical Co. EC JP3463000004 4,300 4,300 112 0.0675
2024-02-27 2023-12-31 NP Takeda Pharmaceutical Co. EC JP3463000004 0 -4,300 -100.00 0 -100.00
2023-11-22 2023-09-30 NP Takeda Pharmaceutical Co. EC JP3463000004 4,300 1,400 48.28 133 46.15 0.0802
2023-08-25 2023-06-30 NP Takeda Pharmaceutical Co. EC JP3463000004 2,900 -1,200 -29.27 91 -32.09 0.0533
2023-05-26 2023-03-31 NP Takeda Pharmaceutical Co. EC JP3463000004 4,100 -400 -8.89 135 -4.29 0.0795
2023-02-24 2022-12-31 NP Takeda Pharmaceutical Co. EC JP3463000004 4,500 0 0.00 141 20.69 0.0808
2022-11-28 2022-09-30 NP Takeda Pharmaceutical Co. EC JP3463000004 4,500 0 0.00 117 -7.94 0.0686
2022-08-26 2022-06-30 NP Takeda Pharmaceutical Co. EC JP3463000004 4,500 -700 -13.46 126 -14.86 0.0709
2022-05-25 2022-03-31 NP Takeda Pharmaceutical Co. EC JP3463000004 5,200 700 15.56 148 21.31 0.0748
2022-02-25 2021-12-31 NP Takeda Pharmaceutical Co. EC JP3463000004 4,500 0 0.00 123 -17.57 0.0572
2021-11-26 2021-09-30 NP Takeda Pharmaceutical Co. EC JP3463000004 4,500 1,400 45.16 148 42.31 0.0679
2021-08-24 2021-06-30 NP Takeda Pharmaceutical Co. EC JP3463000004 3,100 -500 -13.89 104 -20.61 0.0472
2021-05-25 2021-03-31 NP Takeda Pharmaceutical Co. EC JP3463000004 3,600 -100 -2.70 131 -1.50 0.0598
2021-02-24 2020-12-31 NP Takeda Pharmaceutical Co. EC JP3463000004 3,700 -400 -9.76 134 -8.90 0.0599
2020-11-24 2020-09-30 NP Takeda Pharmaceutical Co. EC JP3463000004 4,100 0 0.00 147 -0.68 0.0693
2020-08-24 2020-06-30 NP Takeda Pharmaceutical Co. EC JP3463000004 4,100 -700 -14.58 147 0.68 0.0705
2020-05-26 2020-03-31 NP Takeda Pharmaceutical Co. EC JP3463000004 4,800 2,100 77.78 146 58.70 0.0720
2019-11-25 2019-09-30 NP Takeda Pharmaceutical Co. EC JP3463000004 2,700 2,700 93 0.0394
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.